‘They Need Each Other’: Why Hims & Hers and Novo Nordisk Made Up
Novo Nordisk dropped its lawsuit against Hims & Hers and launched a new collaboration. The deal is advantageous for both companies, experts say.
Novo Nordisk dropped its lawsuit against Hims & Hers and launched a new collaboration. The deal is advantageous for both companies, experts say.
Healthcare AI customers are demanding clear, measurable ROI before they scale adoption. Here, four investors discussed how the healthcare AI startups are adapting to this new market dynamic.
Amazon is launching pharmacy kiosks at One Medical clinics to streamline prescription access, but experts question the model’s scalability, accessibility and long-term viability.
The boutique healthcare investment conference in Chicago is scheduled for May 21-22. Space is limited so register today!
In an interview last week, Larry Cohen — CEO of Health 2047, the American Medical Association’s venture studio — noted that digital health programs have proven to do a good job of improving patient outcomes — but only for certain groups. As technology continues to advance, he urged healthcare leaders not to underestimate the effectiveness of engaging patients by having boots on the ground.
Read news from PromptHealth, HealthMine, Health2047, Sound Life Sciences, and more.
How to turn analytics into actual policy outcomes.
Called RecoverX, the company will leverage AI to mine evidence-based research, medical charts, patient conversations and test results and provide clinical insights for clinicians in real time.
The health plan hopes to better address the needs of underserved populations through community-based teams that can understand and overcome social barriers to care.
A panel discussion at the upcoming MedCity INVEST meeting in Chicago will look at real-world applications of blockchain technology in healthcare and biopharma.
With $2 million in seed funding, the company, First Mile Care, is utilizing a coaching and support model in an effort to reverse prediabetes.
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
"If you just introduce technologies but don't embed them in a practical user experience, they're not going to be helpful," Lúcia Soares, managing director at Health2047, said in a phone interview.
Health2047 CEO Lawrence Cohen outlined the company's strategy following the group's first spinoff last year of health data network business Akiri, previously known as Switch.
The launch of the business is intended to make it easier to transmit data between pharmacies, patients and physicians. It's also part of a wider effort by Health2047, affiliated with the American Medical Association, to make clinicians a driving force in health IT innovation.
Health2047 Switch is one of several new businesses the group plans to launch.
Dr. Doug Given, Health2047 CEO, said In a phone interview that Celgene is the first of many collaboration partners that will be announced this year.